Related Experiment Video
Updated: May 18, 2026
03:23
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Update on eosinophilic lung diseases
1Division of Pulmonary, Allergy, Critical Care Medicine, and Sleep Medicine, The Ohio State University, Columbus, OH 43210, USA. Nitin.Bhatt@osumc.edu
Seminars in Respiratory and Critical Care Medicine
|September 25, 2012
Summary
Eosinophilic lung diseases involve increased eosinophils in the blood or lungs. Diagnosis requires thorough evaluation, including history, exposures, and often bronchoscopy or lung biopsy, to guide treatment.
Area of Science:
- Pulmonology
- Immunology
Background:
- Eosinophilic lung diseases are characterized by elevated eosinophils in the blood and/or lung tissue.
- These conditions can be primary or secondary to other systemic issues, infections, drug reactions, or malignancies.
Purpose of the Study:
- To outline the diagnostic approach for patients presenting with suspected eosinophilic lung disease.
- To emphasize the importance of identifying the specific etiology for effective therapeutic decisions.
Main Methods:
- Comprehensive patient history and physical examination.
- Review of potential exposures (environmental, occupational, medications).
- Diagnostic testing, potentially including bronchoscopy with bronchoalveolar lavage or lung biopsy.
Main Results:
- Eosinophilic lung disease is suspected based on pulmonary findings coupled with blood eosinophilia, bronchoalveolar lavage eosinophilia, or lung tissue eosinophilia.
- Establishing a specific cause is crucial for tailoring treatment strategies.
Conclusions:
- A systematic diagnostic workup is essential for managing eosinophilic lung diseases.
- Accurate etiological diagnosis directly impacts patient outcomes and treatment selection.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...